Literature DB >> 27288920

Agrimonolide from Agrimonia pilosa suppresses inflammatory responses through down-regulation of COX-2/iNOS and inactivation of NF-κB in lipopolysaccharide-stimulated macrophages.

Lei Chen1, Hui Teng1, Ting Fang2, Jianbo Xiao3.   

Abstract

BACKGROUND: Agrimonolide from Agrimonia pilosa showed a strong anti-inflammatory activity, and the present study aims to reveal potential mechanisms on molecular level explaining its anti-inflammatory effect. HYPOTHESIS/
PURPOSE: To investigate the mechanism of anti-inflammatory activity of agrimonolide. STUDY
DESIGN: Anti-inflammatory activity of agrimonolide in cells was applied.
METHODS: Anti-inflammatory activity of agrimonolide isolated from Agrimonia pilosa was evaluated using lipopolysaccharide (LPS) stimulated RAW 264.7 cell models. The productions of IL-1β, IL-6, TNF-α and NO were determined by ELISA and nitrite analysis, respectively. The expressions of iNOS and COX-2 were measured by western blotting and RT-PCR analysis.
RESULTS: The pre-treatment with agrimonolide significantly reduced the levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), as well as attenuated the expression of iNOS and COX-2 in LPS-stimulated macrophages. Furthermore, agrimonolide inhibited the activation of JNK and p38 MAPKs and decreased the activation of JAK-STAT and NF-κB in LPS-stimulated macrophages.
CONCLUSION: The present study suggested that agrimonolide exerted anti- inflammatory activity, at least in part, via suppressing LPS-induced activation of JAK-STATs and p38 MAPKs signaling pathway.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Agrimonolide; Anti-inflammation; Macrophages; Mechanism

Mesh:

Substances:

Year:  2016        PMID: 27288920     DOI: 10.1016/j.phymed.2016.03.016

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  22 in total

1.  The Anti-inflammatory Activities of Two Major Withanolides from Physalis minima Via Acting on NF-κB, STAT3, and HO-1 in LPS-Stimulated RAW264.7 Cells.

Authors:  Rui-Jun Li; Cai-Yun Gao; Chao Guo; Miao-Miao Zhou; Jun Luo; Ling-Yi Kong
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

Review 2.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

Review 3.  Solving the puzzle: What is behind our forefathers' anti-inflammatory remedies?

Authors:  Javier Rodriguez Villanueva; Jorge Martín Esteban; Laura Rodríguez Villanueva
Journal:  J Intercult Ethnopharmacol       Date:  2016-12-08

4.  Agrimonolide and Desmethylagrimonolide Induced HO-1 Expression in HepG2 Cells through Nrf2-Transduction and p38 Inactivation.

Authors:  Lei Chen; Hui Teng; Kalin Yanbo Zhang; Krystyna Skalicka-Woźniak; Milen I Georgiev; Jianbo Xiao
Journal:  Front Pharmacol       Date:  2017-01-11       Impact factor: 5.810

5.  Bioassay-Guided Isolation of Anti-Inflammatory Components from the Bulbs of Lilium brownii var. viridulum and Identifying the Underlying Mechanism through Acting on the NF-κB/MAPKs Pathway.

Authors:  Ting Ma; Zhen Wang; Yang-Mei Zhang; Jian-Guang Luo; Ling-Yi Kong
Journal:  Molecules       Date:  2017-03-23       Impact factor: 4.411

6.  Cerevisterol Alleviates Inflammation via Suppression of MAPK/NF-κB/AP-1 and Activation of the Nrf2/HO-1 Signaling Cascade.

Authors:  Md Badrul Alam; Nargis Sultana Chowdhury; Md Hossain Sohrab; Md Sohel Rana; Choudhury Mahmood Hasan; Sang-Han Lee
Journal:  Biomolecules       Date:  2020-01-29

7.  Anti-Osteoporotic Activity of an Edible Traditional Chinese Medicine Cistanche deserticola on Bone Metabolism of Ovariectomized Rats Through RANKL/RANK/TRAF6-Mediated Signaling Pathways.

Authors:  Bo Zhang; Ling-Ling Yang; Shu-Qin Ding; Jing-Jing Liu; Yan-Hong Dong; Yan-Ting Li; Nan Li; Xiao-Jun Zhao; Chang-Ling Hu; Yiping Jiang; Xue-Qin Ma
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

8.  Screening of traditional Chinese medicines with therapeutic potential on chronic obstructive pulmonary disease through inhibiting oxidative stress and inflammatory response.

Authors:  Ming-Xing Zhou; Xuan Wei; Ai-Ling Li; Ai-Min Wang; Ling-Zi Lu; Yue Yang; Dong-Mei Ren; Xiao-Ning Wang; Xue-Sen Wen; Hong-Xiang Lou; Tao Shen
Journal:  BMC Complement Altern Med       Date:  2016-09-13       Impact factor: 3.659

9.  Ma Xing Shi Gan Decoction Attenuates PM2.5 Induced Lung Injury via Inhibiting HMGB1/TLR4/NFκB Signal Pathway in Rat.

Authors:  Yu-Xiang Fei; Bo Zhao; Qi-Yang Yin; Yan-Ying Qiu; Guang-Hui Ren; Bo-Wen Wang; Ye-Fang Wang; Wei-Rong Fang; Yun-Man Li
Journal:  Front Pharmacol       Date:  2019-11-14       Impact factor: 5.810

10.  The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4+ T Cell Cytotoxicity.

Authors:  Lixin Wang; Wenbin Wu; Xiaowen Zhu; Wanyi Ng; Chenyuan Gong; Chao Yao; Zhongya Ni; Xuewei Yan; Cheng Fang; Shiguo Zhu
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.